In Vitro and In vivo studies identify important features of dengue virus pr-E protein interactions

PLoS Pathogens

Volumn 6, Issue 10, 2010, Pages

  Zheng, Aihua ^a   Umashankar, Mahadevaiah ^a,b   Kielian, Margaret ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; HISTIDINE; PRM PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CELL STRAIN HEK293; DENGUE; DENGUE VIRUS; FLAVIVIRUS; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PH; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; VIRUS ASSEMBLY; VIRUS PARTICLE; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; DROSOPHILA; HUMAN; METABOLISM; MOLECULAR GENETICS; MOSQUITO; MOUSE; PHYSIOLOGY; PROTEIN DOMAIN; SECRETORY PATHWAY; SEQUENCE HOMOLOGY;

DENGUE VIRUS; FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CULICIDAE; DENGUE VIRUS; DROSOPHILA; FLAVIVIRUS; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; SECRETORY PATHWAY; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRUS ASSEMBLY;

EID: 78449249672     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001157     Document Type: Article

References (70)

1. Morens DM, Folkers GK, Fauci AS (2004) The challenge of emerging and reemerging infectious diseases. Nature 430: 242-249.
2. Mackenzie JS, Gubler DJ, Petersen LR (2004) Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10: S98-109.
3. Weaver SC, Barrett AD (2004) Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Micro 2: 789-801.
4. Lindenbach BD, Thiel H-J, Rice CM (2007) Flaviviruses: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields' Virology. Fifth ed. Philadelphia: Lippincott, Williams and Wilkins. pp 1101-1152.
5. Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10: 100-103.
6. Halstead SB (2007) Dengue. Lancet 370: 1644-1652.
7. Kyle JL, Harris E (2008) Global spread and persistence of dengue. Annu Rev Microbiol 62: 71-92.
8. WHO (2009) Dengue and Dengue Haemorrhagic Fever.WHO Fact Sheet N.117.
9. Whitehead SS, Blaney JE, Durbin AP, Murphy BR (2007) Prospects for a dengue virus vaccine. Nat Rev Micro 5: 518-528.
10. Morens DM, Fauci AS (2008) Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA 299: 214-216.
11. Mukhopadhyay S, Kuhn RJ, Rossmann MG (2005) A structural perspective of the flavivirus life cycle. Nat Rev Micro 3: 13-22.
12. van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ, et al. (2007) Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81: 12019-12028.
13. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, et al. (2008) Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4: e1000244.
14. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2A resolution. Nature 375: 291-298.
15. Modis Y, Ogata S, Clements D, Harrison SC (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100: 6986-6991.
16. Modis Y, Ogata S, Clements D, Harrison SC (2005) Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79: 1223-1231.
17. Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH (2006) Crystal structure of the West Nile virus envelope glycoprotein. J Virol 80: 11467-11474.
18. Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, et al. (2006) Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 80: 11000-11008.
19. Zhang Y, Zhang W, Ogata S, Clements D, Strauss JH, et al. (2004) Conformational changes of the flavivirus E glycoprotein. Structure (Camb) 12: 1607-1618.
20. Kuhn RJ, Zhang W, Rossman MG, Pletnev SV, Corver J, et al. (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108: 717-725.
21. Modis Y, Ogata S, Clements D, Harrison SC (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427: 313-319.
22. Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, et al. (2004) Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23: 728-738.
23. Lescar J, Roussel A, Wien MW, Navaza J, Fuller SD, et al. (2001) The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 105: 137-148.
24. Roussel A, Lescar J, Vaney M-C, Wengler G, Wengler G, et al. (2006) Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus. Structure 14: 75-86.
25. Gibbons DL, Vaney M-C, Roussel A, Vigouroux A, Reilly B, et al. (2004) Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 427: 320-325.
26. Sanchez-San Martin C, Liu CY, Kielian M (2009) Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol 17: 514-521.
27. Harrison SC (2008) Viral membrane fusion. Nat Struct Mol Biol 15: 690-698.
28. Kielian M, Rey FA (2006) Virus membrane fusion proteins: more than one way to make a hairpin. Nat Rev Micro 4: 67-76.
29. Sanchez-San Martin C, Sosa H, Kielian M (2008) A stable prefusion intermediate of the alphavirus fusion protein reveals critical features of class II membrane fusion. Cell Host Microbe 4: 600-608.
30. Liao M, Sanchez-San Martin C, Zheng A, Kielian M (2010) In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J Virol 84: 5730-5740.
31. Paroutis P, Touret N, Grinstein S (2004) The pH of the secretory pathway: measurement, determinants, and regulation. Physiology (Bethesda) 19: 207-215.
32. Wengler G (1989) Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol 63: 2521-2526.
33. Stadler K, Allison SL, Schalich J, Heinz FX (1997) Proteolytic activation of tickborne encephalitis virus by furin. J Virol 71: 8475-8481.
34. Li L, Lok SM, Yu IM, Zhang Y, Kuhn RJ, et al. (2008) The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319: 1830-1834.
35. Yu IM, Holdaway HA, Chipman PR, Kuhn RJ, Rossmann MG, et al. (2009) Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol 83: 12101-12107.
36. Yu IM, Zhang W, Holdaway HA, Li L, Kostyuchenko VA, et al. (2008) Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319: 1834-1837.
37. Lorenz IC, Allison SL, Heinz FX, Helenius A (2002) Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol 76: 5480-5491.
38. Lin YJ, Wu SC (2005) Histidine at residue 99 and the transmembrane region of the precursor membrane prM protein are important for the prM-E heterodimeric complex formation of Japanese encephalitis virus. J Virol 79: 8535-8544.
39. Ivy J, Nakano E, Clements D (2000) Subunit immunogenic composition against dengue infection. US Patent 6,165,477.
40. Junjhon J, Lausumpao M, Supasa S, Noisakran S, Songjaeng A, et al. (2008) Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction. J Virol 82: 10776-10791.
41. Liao M, Kielian M (2005) Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus-membrane fusion. J Cell Biol 171: 111-120.
42. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, et al. (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328: 745-748.
43. Kroschewski H, Sagripanti JL, Davidson AD (2009) Identification of amino acids in the dengue virus type 2 envelope glycoprotein critical to virus infectivity. J Gen Virol 90: 2457-2461.
44. Allison SL, Stadler K, Mandl CW, Kunz C, Heinz FX (1995) Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol 69: 5816-5820.
45. Lorenz IC, Kartenbeck J, Mezzacasa A, Allison SL, Heinz FX, et al. (2003) Intracellular assembly and secretion of recombinant subviral particles from tickborne encephalitis virus. J Virol 77: 4370-4382.
46. Hsieh SC, Liu IJ, King CC, Chang GJ, Wang WK (2008) A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles. Virology 374: 338-350.
47. Corver J, Ortiz A, Allison SL, Schalich J, Heinz FX, et al. (2000) Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology 269: 37-46.
48. Wang PG, Kudelko M, Lo J, Siu LY, Kwok KT, et al. (2009) Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. PLoS ONE 4: e8325.
49. Lisova O, Hardy F, Petit V, Bedouelle H (2007) Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus. J Gen Virol 88: 2387-2397.
50. Thullier P, Lafaye P, Megret F, Deubel V, Jouan A, et al. (1999) A recombinant Fab neutralizes dengue virus in vitro. J Biotechnol 69: 183-190.
51. Crill WD, Chang GJ (2004) Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol 78: 13975-13986.
52. Konishi E, Mason PW (1993) Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol 67: 1672-1675.
53. Demaurex N, Furuya W, D'Souza S, Bonifacino JS, Grinstein S (1998) Mechanism of acidification of the trans-Golgi network (TGN). In situ measurements of pH using retrieval of TGN38 and furin from the cell surface. J Biol Chem 273: 2044-2051.
54. Zhang X, Fugere M, Day R, Kielian M (2003) Furin processing and proteolytic activation of Semliki Forest virus. J Virol 77: 2981-2989.
55. Stiasny K, Allison SL, Schalich J, Heinz FX (2002) Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J Virol 76: 3784-3790.
56. Fritz R, Stiasny K, Heinz FX (2008) Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol 183: 353-361.
57. Nelson S, Poddar S, Lin TY, Pierson TC (2009) Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the "histidine switch" hypothesis. J Virol 83: 12631-12635.
58. Schmidt AG, Yang PL, Harrison SC (2010) Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog 6: e1000851.
59. Kaufmann B, Chipman PR, Holdaway HA, Johnson S, Fremont DH, et al. (2009) Capturing a flavivirus pre-fusion intermediate. PLoS Pathog 5: e1000672.
60. Vashishtha M, Phalen T, Marquardt MT, Ryu JS, Ng AC, et al. (1998) A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit. J Cell Biol 140: 91-99.
61. Taylor GM, Hanson PI, Kielian M (2007) Ubiquitin depletion and dominantnegative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. J Virol 81: 13631-13639.
62. Umashankar M, Sanchez San Martin C, Liao M, Reilly B, Guo A, et al. (2008) Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J Virol 82: 9245-9253.
63. Thomas JM, Klimstra WB, Ryman KD, Heidner HW (2003) Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein. J Virol 77: 5598-5606.
64. Stiasny K, Kiermayr S, Holzmann H, Heinz FX (2006) Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. JVirol 80: 9557-9568.
65. Wang P, Chen J, Zheng A, Nie Y, Shi X, et al. (2004) Expression cloning of functional receptor used by SARS coronavirus. Biochem Biophys Res Comm 315: 439-444.
66. Chatterjee PK, Vashishtha M, Kielian M (2000) Biochemical consequences of a mutation that controls the cholesterol dependence of Semliki Forest virus fusion. J Virol 74: 1623-1631.
67. Cass B, Pham PL, Kamen A, Durocher Y (2005) Purification of recombinant proteins from mammalian cell culture using a generic double-affinity chromatography scheme. Protein Expr Purif 40: 77-85.
68. Puri B, Polo S, Hayes CG, Falgout B (2000) Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain. Virus Genes 20: 57-63.
69. Chanel-Vos C, Kielian M (2004) A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion. J Virol 78: 13543-13552.
70. Liljeström P, Lusa S, Huylebroeck D, Garoff H (1991) In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol 65: 4107-4113.